Souhaitez-vous accéder aux communiqués récents ?

Sonablate launched their SONA FUSION Registry, a first-of-its-kind global outcomes initiative designed to unify international real-world evidence for HIFU.

MELBOURNE, Australia , May 13, 2026 (GLOBE NEWSWIRE) -- Propanc Biopharma, Inc. (Nasdaq: PPCB) (“Propanc” or the “Company”), a biopharmaceutical company focused on developing novel treatments for...

AMSTERDAM, May 11, 2026 (GLOBE NEWSWIRE) -- WhyDonate, a global online crowdfunding platform, released a new report analysing the growth of medical crowdfunding across Europe and the healthcare...

WASHINGTON, D.C., May 06, 2026 (GLOBE NEWSWIRE) -- The Support Is Care Summit brought people living with cancer, caregivers, and providers from across the country to Washington, D.C., to advocate...

Brad Saar joins Sonablate board to support growth of non-invasive prostate cancer treatment to signal next phase of expansion for HIFU-based prostate care.

With AI tools demonstrating 85–95% accuracy in biomarker identification and attracting more than $3 billion in recent funding.

Tovecimig Demonstrates Significant Benefit in Randomized Phase 2/3 Study in Patients with Biliary Tract Cancer

Providence Saint John’s announced the largest philanthropic gift in its history, an estate gift estimated at $100 million from the late Stan Lucas.

Radioligand Therapeutics Market in Cancer Treatment to Reach $4.8 Billion by 2030, Reports BCC Research

Messino Cancer Centers Opens New Asheville Clinic